{"name":"Encube Ethicals Pvt. Ltd.","slug":"encube-ethicals-pvt-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Elimite™ Cream (permethrin) 5%","genericName":"Elimite™ Cream (permethrin) 5%","slug":"elimite-cream-permethrin-5","indication":"Scabies (Sarcoptes scabiei infestation)","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Solaraze 3% Topical Gel","genericName":"Solaraze 3% Topical Gel","slug":"solaraze-3-topical-gel","indication":"Moderate to severe plaque psoriasis","status":"phase_3"}]}],"pipeline":[{"name":"Elimite™ Cream (permethrin) 5%","genericName":"Elimite™ Cream (permethrin) 5%","slug":"elimite-cream-permethrin-5","phase":"phase_3","mechanism":"Permethrin is a synthetic pyrethroid insecticide that disrupts sodium channel function in the nervous system of parasites, causing paralysis and death.","indications":["Scabies (Sarcoptes scabiei infestation)","Head lice (Pediculus humanus capitis infestation)"],"catalyst":""},{"name":"Solaraze 3% Topical Gel","genericName":"Solaraze 3% Topical Gel","slug":"solaraze-3-topical-gel","phase":"phase_3","mechanism":"Solaraze 3% Topical Gel is a topical gel formulation of tazarotene, a retinoid that modulates the expression of genes involved in cell proliferation and differentiation.","indications":["Moderate to severe plaque psoriasis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOWEJpV1p1cXR2Y3NmV0kwc0wxMEVIbzVYR3BicFVCRW5aV3NvcDFhaEoxTHF0YVVHS0YtSkVrc2NIdnBERTMyazF3RlZmV19FSFZGcjdtTFFXSldUZnhVdUVkWkxxQlpZWHZic3c4U0ZodS1MVnkxU0VWVGt0Rm9tdTcyalJOWFJ0ZVhQM1VqOFNJLTBDLVZyOHktbExUNHgtV2o0c3FfZ3o5YXVOMGlsb1ppc2E2aG9NVVY1VnFTNVFCWjBwVEcyN3BzTU9VWGlyTUFNdUtYdDM?oc=5","date":"2026-02-12","type":"deal","source":"EnterpriseAM Egypt","summary":"Mubadala-Warburg in the lead to acquire Indian pharma outfit Encube Ethicals at USD 1.8 bn valuation - EnterpriseAM Egypt","headline":"Mubadala-Warburg in the lead to acquire Indian pharma outfit Encube Ethicals at USD 1.8 bn valuation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2026-02-11","type":"pipeline","source":"The Economic Times","summary":"Warburg-Mubadala team up, emerge as frontrunner for Encube - The Economic Times","headline":"Warburg-Mubadala team up, emerge as frontrunner for Encube","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNYXVBX1BMZXl3WXRvQVFkNU9pTDhDVlNfTlVvRlhOSlBaSHJ4VTMwZ3AyNng1YndYV0lyZXdreW9jYWR5dVZpUWdLZkNYV2FiSUsyeEFMT3hNSEg2YXhIbkJubXplV1NCbFJqRFp6bUkyWWJpd3FXMG5DaXR0Y2cwOHo5eWtqYk8xQ3VPellfRGJ4NWxaQVNPQjNNZ1V0MjRwTG0wTGdxSdIBtAFBVV95cUxNU05hclR4dzAtbDhEOW5GWFAzU0k0QUFIT21WeGhpWGlwNkxrdGItb0tVd0VKWi1tNEdqcE9XOHZvR3R3eDNwT1I0V1R2Tlk1QzdqZkJ6c3puS05UekdJdHlxY09uTHRHQjAteTVRaHBiN0F0RFVrWXhtMXJmMXF2N1ZOQ211NGxUeVJDT0dYTzk2VmR3Q3YwX3FIQTRtWEQtUzVudDZDbWJ3bTVGVlR0dEpNQU0?oc=5","date":"2026-02-11","type":"pipeline","source":"outlookbusiness.com","summary":"Warburg-Mubadala Lead the Race For Mehul Shah's Encube Ethicals - outlookbusiness.com","headline":"Warburg-Mubadala Lead the Race For Mehul Shah's Encube Ethicals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQSEtrNXJRNmpLSEw1Z0ZKaEVqZmR2ZVc5Tm1HUU5ibGNIZXR5QkpWcGpiSkc1OUlWTzMwdzZzaENRWTZzUVpkODhVZ2Nsa29Qd181WG9TVWhNdE9hUXNLQXNWVUlqMFFZV1E3dDAxZGtOeVVJYVh2OU5DNDFKR3I5UEdtT2h5R1kyQ2VGM1VHOTFZNzNnX0N1bzBqbFZkQW5iTjVkZG5SaEJLdmhxZ2xPRjA2MFFxUW1DdzN2TlpiN2N1VFFqYTNlQXlONHg5Rm4wZTlKODFvelM?oc=5","date":"2026-02-11","type":"deal","source":"EnterpriseAM Egypt","summary":"Warburg-Mubadala in the lead to acquire Indian pharma Encube Ethicals at USD 1.8 bn valuation - EnterpriseAM Egypt","headline":"Warburg-Mubadala in the lead to acquire Indian pharma Encube Ethicals at USD 1.8 bn valuation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOdDY0YXpYTWJRUV9wTm5Ra0JDSTVtZ0U1MU9tLUpSMEpCaWZRZUhiQWZhWXVKUy1QOGFmVGx2YktrcmNJMlhZdVVIb1ZJb3NpT1ZTWGpVUWplZThzYlljdUNqTVpxWlB0TUI2QmxmV1p1cVl3enV2VmQwUnBOdUlQMG80RDh6TnF2VGJnZzY2SlZSeWJRYS1WRnJyblR2OGVra1ZhRnpHeXV5ZDBjWjFVT3ljU0hjSkZLYUJtSmJSYzZMS0xqLUJpTC0tYkhFREUtRzRxX3prR3VwTXNQSjZUWjVzcXAycXUySFM3TnF5MFd5Zw?oc=5","date":"2026-02-11","type":"deal","source":"Whalesbook","summary":"Warburg-Mubadala Nears $1.8B Buyout of Indian Pharma Firm Encube Ethicals - Whalesbook","headline":"Warburg-Mubadala Nears $1.8B Buyout of Indian Pharma Firm Encube Ethicals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOaVFqcEx2N29mTDFteFI1OFVyNUJhQUI2SEhjWWtrWWJQNmFsLW9PMTBVMjhQWUxyUm5KX3J4Zk5yUDFHd0hTWTFCeEI1QkZiX0hoTmlUampFN19YSTNVc2dab01hUzBJcEU1YnB2NjJJMktuMnRfd0xnNzJyR0hKS1hncXNBSDhhS2t6UmNCNG9laTlyaldINkhzaWk2dERQRnhfbUFMQ0pJcHdlbGdCYlk2NA?oc=5","date":"2026-01-20","type":"deal","source":"ET Now","summary":"Warburg, EQT compete to buy topical pharma firm Encube Stake - ET Now","headline":"Warburg, EQT compete to buy topical pharma firm Encube Stake","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOZWtRaGV6V1JlOUdveF92RmdxcEJweVY1NHMyNWJWUUVGOTFTU29IZnFEU2gzVWYyWE1LcTh5OW9hME5vODdxTEtWV1JZeG1Gc2pFUVdEZ3VDbW1FQXFuV0NLRW51RXgxbDJfWTNwYjYyMzhLdWVLMnJ3YUkzV1YtUG5iVjBnWnJUSGVoazhFMjZIVnEwMExteXNQYUM0UE83dGRpRDJ0RmxIeUF0NEFZd2Qwdy1kVGZENExJeE1tanJVdTdaVHVxa3RnaXFSOXlyb2pOeU1wN0ttRzQ2OFlrdnJR?oc=5","date":"2026-01-20","type":"pipeline","source":"scanx.trade","summary":"Warburg Pincus and EQT Compete for Minority Stake in Topical Pharma Firm Encube Ethicals - scanx.trade","headline":"Warburg Pincus and EQT Compete for Minority Stake in Topical Pharma Firm Encube Ethicals","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-17","type":"pipeline","source":"Mint","summary":"Advent, Warburg join race for stake in Encube Ethicals - Mint","headline":"Advent, Warburg join race for stake in Encube Ethicals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxOQzF2WWRWUklhUl9RdlpLSVBaajBJYjFsV2czN1BKNkIwRkFQcTBIMkxxRWNmNkFaZHBzcDZINzVBd2dPUUJJWGhId1pzWXNjOFJjUC12Umc4bjNZVkdPWm1paHRPeV9WUjFGaXNuVFVOOU5weml0RjR1YVlvVXRRak9wSVJRdjJKMURVckdHWFBfZ0RGUEhfOThiOXVjV0FSYW9YNVVpWFY4OUZoVkNlMTFzc283ZU5GT005LU1teEIyUnFDNUtKa2FIVXdBLVlDdXk5ZW1DRXVZZXRUQ256RG5PMWc0bTRMRXRvNEJiejZGMWNFVmFCSzZrUnJHOFFUV3c?oc=5","date":"2025-11-17","type":"pipeline","source":"Whalesbook","summary":"Encube Ethicals: Advent, Warburg Pincus Lead Race for Stake in $2.3 Billion Pharma CDMO - Whalesbook","headline":"Encube Ethicals: Advent, Warburg Pincus Lead Race for Stake in $2.3 Billion Pharma CDMO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5jd0xiMzI2ZkxrbnQ0d09TeEVCUFgtUXRHVFJKQ1pESzFVM0ZyRGswOTl0cFB5UldDQ0NkZC1YUS1NeDZHUHA1RFRIbEp3UUlWTHQxMExTdWNaS3ZPeTJCdW1jVjV2M2JXcXpB?oc=5","date":"2025-10-24","type":"pipeline","source":"Pharmabiz.com","summary":"PM&AC 2025 redefines excellence in pharma manufacturing - Pharmabiz.com","headline":"PM&AC 2025 redefines excellence in pharma manufacturing","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-08-13","type":"pipeline","source":"expresspharma.in","summary":"Sustainability is more than a commitment, it's a path to operational efficiency and long-term value creation - expresspharma.in","headline":"Sustainability is more than a commitment, it's a path to operational efficiency and long-term value creation","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-05-24","type":"pipeline","source":"The Times of India","summary":"One more pharma firm in Goa backtracks on Maharashtra hiring drive after backlash - The Times of India","headline":"One more pharma firm in Goa backtracks on Maharashtra hiring drive after backlash","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}